Sponsor:
Teclison Ltd.
Code:
NCT04701476
Conditions
Colorectal Cancer; Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
TATE and pembrolizumab
TAS-102 pill
Regorafenib Pill
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations